| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4237821 | Journal of Vascular and Interventional Radiology | 2017 | 10 Pages |
Abstract
Modified target mRECIST and EASL criteria that employ delayed-phase contrast enhancement at 3 months after 90Y radioembolization therapy for ICC predicted OS. RECIST did not correlate with survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Juan C. MD, Nima MD, Minzhi MD, Hasmukh J. MD, Bassel MD, Hyun S. MD,